Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: A multi-centre randomised controlled trial

Journal of Affective Disorders

Volumn 109, Issue 3, 2008, Pages 273-285

  Knapp, Martin ^a,b   Romeo, Renee ^a   Mogg, Andrew ^a   Eranti, Savitha ^a   Pluck, Graham ^a   Purvis, Rick ^a   Brown, Richard G ^a   Howard, Robert ^a   Philpot, Michael ^c   Rothwell, John ^d   Edwards, Denzil ^e   McLoughlin, Declan M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e KENT AND MEDWAY NHS AND SOCIAL CARE PARTNERSHIP TRUST   (United Kingdom)

Author keywords

Cost effectiveness; Depression; Electroconvulsive therapy; Quality of life; Repetitive transcranial magnetic stimulation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

AGED; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 45849109204     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.01.001     Document Type: Article

References (25)

1. Barrett B., Byford S., and Knapp M. Evidence of cost-effective treatments for depression: a systematic review. Journal of Affective Disorders 84 (2005) 1-13
2. Beecham J., and Knapp M. Costing psychiatric interventions. In: Thornicroft G., Brewin C., and Wing J. (Eds). Measuring Mental Health Needs (1992), Gaskell, London 163-183
3. Beecham J., and Knapp M. Costing psychiatric Interventions. In: Thornicroft G. (Ed). Measuring Mental Health Needs. Second edition (2000), Gaskell, London
4. Brazier J.E., Roberts J., and Deverill M. The estimation of a preference based measure of health from the SF-36. Journal of Health Economics 21 (2002) 271-292
5. Briggs A. Economic evaluation and clinical trials: size matters (editorial). British Medical Journal 321 (2000) 1362-1363
6. Curtis L., and Netten A. Unit Costs of Health and Social Care (2004), PSSRU, University of Kent
7. Department of Health. National Health Service Schedule of Reference Costs 2004 (2004). http://www.doh.gov.uk/nhsexec/refcosts.htm http://www.doh.gov.uk/nhsexec/refcosts.htm. [accessed May 2005]
8. Devlin N., and Parkin D. Does NICE have a cost effectiveness threshold, and what other factors influence its decisions?. A binary choice model. Health Economics 13 (2004) 437-452
9. Dunn G., Mirandola M., Amaddeo F., and Tansella M. Describing, explaining or predicting mental health care costs: a guide to regression models. British Journal of Psychiatry 183 (2003) 398-404
10. Eranti S., Mogg A., Pluck G., Landau S., Purvis R., Brown R.G., Howard R., Knapp M., Philpot M., Rabe-Hesketh S., Romeo R., Rothwell J., Edwards D., and McLoughlin D.M. A randomized controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. American Journal of Psychiatry 164 (2007) 73-81
11. Fenwick E., O'Brien B., and Briggs A. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Economics 13 (2004) 405-415
12. George M.S., Lisanby S.H., and Sackheim H.A. Transcranial magnetic stimulation - applications in neuropsychiatry. Archives of General Psychiatry 56 (1999) 300-311
13. Greenhalgh J., Knight C., Hind D., Beverley C., and Walters S. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: Systematic reviews and economic modelling studies. Health Technology Assessment 9 (2005) 9
14. Grunhaus L., Schreiber S., Dolberg Plack D., and Dannon P.N. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation on severe and resistant nonpsychotic major depression. Biological Psychiatry 15:53 4 (2003) 324-331
15. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry (1960) 2356-2362
16. Kozel F.A., George M.S., and Simpson K.N. Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression. CNS Spectrums 9 6 (2004) 476-482
17. McCall W.V., Reboussin B.A., Cohen W., and Lawton P. Electroconvulsive therapy is associated with superior symptomatic and functional change in depressed patients after psychiatric hospitalization. Journal of Affective Disorders 63 (2001) 17-25
18. McCall W., Dunn A., and Rosenquist P.B. Quality of life and function after ECT. British Journal of Psychiatry 185 (2004) 405-409
19. Rose D., Wykes T., Leese M., Bindman J., and Fleischmann P. Patients' perspectives on electroconvulsive therapy: systematic review. British Medical Journal 326 (2003) 1363-1365
20. Royal College of Psychiatrists. The ECT Handbook: The Second Report of the Royal College of Psychiatrists' Special Committee on ECT (1995), Royal College of Psychiatrists, London [Council Report CR39]
21. Sackeim H.A., Prudic J., Devanand D.P., Kiersky J.E., Fitzsimons L., Moody B.J., Mcelhiney M.C., Coleman E.A., and Settembrino J.M. Effects of stimulus-intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive-therapy. New England Journal of Medicine 328 (1993) 839-846
22. Sturm R., Unutzer J., and Katon W. Effectiveness research for study design: sample size and statistical power. General Hospital Psychiatry 21 (1999) 274-283
23. Thomas C., and Morris S. Cost of depression among adults in England in 2000. British Journal of Psychiatry 183 (2003) 514-519
24. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361 (2003) 799-808
25. van Hout B., Al M., Gordon G., and Rutten F. Costs, effects and cost-effective ratios alongside a clinical trial. Health Economics 3 (1994) 309-319